4//SEC Filing
Schelling Chris 4
Accession 0001209191-22-003729
CIK 0001069308other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:29 PM ET
Size
5.8 KB
Accession
0001209191-22-003729
Insider Transaction Report
Form 4
Schelling Chris
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-14+50,000→ 50,000 totalExercise: $2.21Exp: 2032-01-14→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on January 14, 2023, and the remaining 75% of the shares vest quarterly over the remaining three years.
Documents
Issuer
Acer Therapeutics Inc.
CIK 0001069308
Entity typeother
Related Parties
1- filerCIK 0001717241
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 4:29 PM ET
- Size
- 5.8 KB